Immunization, measles second dose in Tajikistan
Tajikistan: Immunization, measles second dose was 97.0% in 2024. ▲ Rising
Immunization, measles second dose in Tajikistan, 1999–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Tajikistan is 97.0%, measured in 2024.
Compared with earlier readings it is up 1.0% on the previous year and down 1.0% over ten years.
Over the whole period, immunization, measles second dose in Tajikistan peaked at 98.0% in 2004 and was at its lowest, 46.0%, in 1999.
Tajikistan ranks 19th of 178 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Immunization, measles second dose in Tajikistan, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 1999 | 46.0% | — |
| 2000 | 59.0% | +28.3% |
| 2001 | 72.0% | +22.0% |
| 2002 | 93.0% | +29.2% |
| 2003 | 94.0% | +1.1% |
| 2004 | 98.0% | +4.3% |
| 2005 | 92.0% | -6.1% |
| 2006 | 96.0% | +4.3% |
| 2007 | 90.0% | -6.2% |
| 2008 | 87.0% | -3.3% |
| 2009 | 93.0% | +6.9% |
| 2010 | 95.0% | +2.2% |
| 2011 | 96.0% | +1.1% |
| 2012 | 97.0% | +1.0% |
| 2013 | 97.0% | +0.0% |
| 2014 | 98.0% | +1.0% |
| 2015 | 94.0% | -4.1% |
| 2016 | 97.0% | +3.2% |
| 2017 | 98.0% | +1.0% |
| 2018 | 97.0% | -1.0% |
| 2019 | 97.0% | +0.0% |
| 2020 | 97.0% | +0.0% |
| 2021 | 96.0% | -1.0% |
| 2022 | 97.0% | +1.0% |
| 2023 | 96.0% | -1.0% |
| 2024 | 97.0% | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 46.0% | 46.0% | 46.0% | 1 |
| 2000s | 87.4% | 59.0% | 98.0% | 10 |
| 2010s | 96.6% | 94.0% | 98.0% | 10 |
| 2020s | 96.6% | 96.0% | 97.0% | 5 |
Countries ranked near Tajikistan
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.6758 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0596 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6416 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, measles second dose in Tajikistan?
- Immunization, measles second dose in Tajikistan was 97.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Tajikistan?
- The highest recorded value was 98.0% in 2004.
- What is the lowest immunization, measles second dose recorded in Tajikistan?
- The lowest recorded value was 46.0% in 1999.
- How does Tajikistan rank for immunization, measles second dose?
- Tajikistan ranks 19th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Tajikistan?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is rising.
- Where does this Tajikistan data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.